Sun Pharma Initiates Phase II Clinical Trial on AQCH as Potential Treatment for COVID-19 Patients
Mumbai: Sun Pharmaceutical Industries has announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19.
The Company received approval from the Drugs Controller…